How to measure insulin sensitivity

Journal of Hypertension

Volumn 16, Issue 7, 1998, Pages 895-906

  Ferrannini, Ele ^a,c   Mari, Andrea ^b  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Clamp technique; Insulin action; Insulin sensitivity

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; CALORIMETRY; CARDIOVASCULAR RISK; CATHETERIZATION; DIET RESTRICTION; DILUTION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; INTRAVENOUS GLUCOSE TOLERANCE TEST; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; TECHNIQUE;

EID: 0031846461     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816070-00001     Document Type: Article

References (61)

1. Ferrannini E. Insulin resistance and disease. In: Baillière's clinical endocrinology & metabolism. London: WB Saunders Company: 1993.
2. Cheatam B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995; 16:117-142.
3. Del Prato S, Ferrannmi E, DeFronzo RA. Evaluation of insulin sensitivity in man. In: Clarke WL, Larner J, Pohl S (editors): Methods in diabetes research, volume II, clinical methods. New York: John Wiley; 1985. pp. 36-76.
4. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6:45-86.
5. Matsuda M, DeFronzo RA, In vivo measurement of insulin sensitivity in humans. In: Draznin B, Rizza RA (editors): Clinical research in diabetes and obesity, volume I, methods, assessment, and metabolic regulation. Totowa, NJ: Humana Press; 1997. pp. 23-65.
6. Andres R, Swerdloff R, Pozefsky T, Coleman D. Manual feedback technique for the control of blood glucose concentration. In: Skeggs LT Jr (editor): Automation in analytical chemistry. New York: Mediad; 1966. pp. 486-491.
7. DeFronzo RA, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
8. DeFronzo RA, Ferrannini E. Influence of plasma glucose and insulin concentrations on plasma glucose clearance in man. Diabetes 1982; 31:683-688.
9. Doberne L, Greenfield MS, Rosenthal M, Widstrom A, Reaven GM. Effect of variations in basal plasma glucose concentration on glucose utilization (M) and metabolic clearance (MCR) rates during insulin clamp studies in patients with non-insulin-dependent diabetes mellitus. Diabetes 1982; 31:396-400.
10. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983; 32:35-45.
11. Gelfand RA, DeFronzo RA. Hypoglycemic counterregulation in normal and diabetic man. Ann Clin Res 1984; 16:84-93.
12. Bonadonna RC, Del Prato S, Cobelli C, Saccomani MP, Bonora E, Gulli G, et al. Transmembrane glucose transport and glucose phosphorylation in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 1993; 92:486-494.
13. Yki-Järvinen H, Young AA, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 1987; 79:1713-1719.
14. Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary artery disease: a study with positron-emitting tomography. J Clin Invest 1996; 98:2094-2099.
15. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322:223-228.
16. Felber J-P, Ferrannini E, Golay A, Meyer E, Thiebaud D, Curchod B, et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 1987; 36:1341-1350.
17. Groop LC, Bonadonna RC, Del Prato S, Ratheiser K, Zyck K, Ferrannini E, et al. Effect of insulin on oxidative and non-oxidative pathways of glucose and FFA metabolism in NIDDM. Evidence for multiple sites of insulin resistance. J Clin Invest 1989, 84:205-213.
18. Gelfand RA, Barrett EJ. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest 1987; 80:1-6
19. DeFronzo RA, Gunnarson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J Clin Invest 1985; 76:149-155.
20. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990; 85:1844-1852.
21. Natali A, Bonadonna R, Santoro D, Quiñones Galvan A, Baldi S, et al. Insulin resistance and vasodilatation in essential hypertension. Studies with adenosine. J Clin Invest 1994; 94:1570-1576.
22. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest 1991; 87:2246-2252
23. Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Baldi S, et al. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 1998 (in press)
24. Kahn SE. Assessment of B-cell function in humans. Approach and interpretation. In: Draznin B, Rizza RA (editors): Clinical research in diabetes and obesity, volume I, methods, assessment, and metabolic regulation. Totowa, NJ: Humana Press; 1997. pp. 3-22.
25. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997, 100:1166-1173.
26. Ferrannini E, Haffner SM, Mitchell BD, Stern MP, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34:416-422.
27. Horgaard A, Thayssen TEH. Clinical investigation into the effect of the intravenous injection of insulin. Acta Med Scand 1929; 72:92-95.
28. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic clamp studies. J Clin Endocrinol Metab 1989; 68:374-378.
29. Ferrannini E, Pilo A. Pattern of insulin delivery after intravenous glucose injection, and its relation to plasma glucose disappearance. J Clin Invest 1979; 64:243-250.
30. Shen S-W, Reaven GM, Farquhar IW. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970; 49:2151-2160.
31. Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, et al. Glucose, insulin and somatostatin infusions for measurement of in vivo insulin resistance. J Clin Endocrinol Metab 1977; 45: 1124-1127.
32. Bergman RN, Ader M, Finegood DT, Pacini G. Extrapancreatic effect of somatostatin infusion to increase glucose clearance. Am J Physiol 1984; 247:E596-E602.
33. Bergman, RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236:E667-E677.
34. Beard JC, Bergman RN, Ward WK, Porte D Jr. The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes 1986; 35:362-369.
35. Finegood DT, Hramiak IM, Dupre J. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990; 70:1538-1549.
36. Welch S, Gebhart SSP, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990; 71:1508-1518.
37. Mari A. Assessment of insulin sensitivity with minimal model: role of model assumptions. Am J Physiol 1997; 272:E925-E934.
38. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-D, et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 1994; 43:1114-1121.
39. Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. Am J Physiol 1996; 270:E532-E540.
40. Coates PA, Luzio SD, Brunel P, Owens DR. Comparison of estimates of nsulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 1995; 44:631-635.
41. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, et al. Pathogenic factors responsible for glucose intolerance in patients with NIDDM, Diabetes 1992; 41:1540-1546.
42. I? Diabetologia 1996; 40:362-364.
43. Finegood DT, Tzur D. Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 1996; 271:E485-E495.
44. Prigeon RL, Roder ME, Porte D Jr, Kahn SE. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. J Clin Invest 1996; 97:501-507.
45. Saad MF, Steil GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R, et al. Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 1997; 46:1167-1171.
46. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, et al. Impaired basal glucose effectiveness in NIDDM. Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 1997; 46:421-432.
47. Best JD, Kahn SE, Ader M, Watanabe RM, Ni T, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996; 19:1018-1030.
48. Henriksen JE, Alford F, Handberg A, Vaag A, Ward GM, Kalfas A, et al. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest 1994; 94: 1196-1204.
49. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 1994; 43:587-592.
50. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, et al. Insulin sensitivity index. acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. J Clin Invest 1996; 98:1195-1209.
51. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 1985; 28:401-411.
52. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
53. Avogaro A, Bristow JD, Bier DM, Cobelli C, Toffolo G. Stable-label intravenous glucose tolerance test minimal model. Diabetes 1989; 38:1048-1055.
54. Cobelli C, Pacini G, Toffolo G, Sacca L. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol 1986; 250:E591-E598.
55. Vicini P, Caumo A, Cobelli C. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol 1997; 273:E829-E841.
56. Mari A, Valerio A. A circulatory model for the estimation of insulin sensitivity. Control Eng Practice 1997; 5:1747-1752.
57. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954; 6:731-744.
58. Zierler KL. Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and non-steady states. J Clin Invest 1961; 40:2111-2125.
59. Mari A, Valerio A, Avogaro A. Assessment of glucose metabolic parameters with the intravenous glucose test and a circulatory model [abstract]. Diabetes 1997; 46 (suppl 1):352A.
60. Steil GM, Murray J, Bergman RN, Buchanan TA. Repeatability of insulin sensitivity and glucose effectiveness from the minimal model. Diabetes 1994; 43:1365-1371.
61. Yang YJ, Youn JH, Bergman RN. Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 1987; 253:E595-E602.